Industry / Algeria
Government Continues To Subsidise Local Drugmakers
January 2011 | Industry Trend AnalysisBMI View: Investment in publicly-owned drugmakers will increase the availability and sales volumes of some generic medicines in Algeria. Since this is in line with BMI's forecasts, specifically that generic drugs' market share is to rise steadily between 2009 and 2019, our projected pharmaceutical sales figures are unchanged.
To read the full article, please choose one of the following options:
Subcribers please log in




